Compare AEIS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | CYTK |
|---|---|---|
| Founded | 1981 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 7.6B |
| IPO Year | 1996 | 2004 |
| Metric | AEIS | CYTK |
|---|---|---|
| Price | $302.19 | $60.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 18 |
| Target Price | ★ $278.36 | $87.56 |
| AVG Volume (30 Days) | 583.9K | ★ 1.7M |
| Earning Date | 05-12-2026 | 05-25-2026 |
| Dividend Yield | ★ 0.13% | N/A |
| EPS Growth | ★ 168.53 | N/A |
| EPS | ★ 3.84 | N/A |
| Revenue | ★ $453,095,000.00 | $13,368,000.00 |
| Revenue This Year | $21.75 | $9.79 |
| Revenue Next Year | $13.24 | $302.66 |
| P/E Ratio | $79.54 | ★ N/A |
| Revenue Growth | ★ 38.39 | N/A |
| 52 Week Low | $75.01 | $29.31 |
| 52 Week High | $350.00 | $70.98 |
| Indicator | AEIS | CYTK |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 41.25 |
| Support Level | $288.91 | $59.25 |
| Resistance Level | $350.00 | $65.93 |
| Average True Range (ATR) | 15.68 | 2.80 |
| MACD | -5.59 | -0.36 |
| Stochastic Oscillator | 20.33 | 14.38 |
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.